A Trial Comparing Qam With Qpm Dosing in Assisted Reproductive Technologies (ART)



Status:Completed
Conditions:Women's Studies, Infertility
Therapuetic Areas:Reproductive
Healthy:No
Age Range:21 - 42
Updated:4/21/2016
Start Date:June 2010
End Date:December 2015

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Prospective Randomized Trial Comparing Qam With Qpm Daily Dosing in Assisted Reproductive Technologies

This is a prospective randomized trial comparing the outcome in women undergoing IVF/ICSI
when taking their gonadotropin dosage in the morning (am) or evening (pm).


Inclusion Criteria:

- women between 21-42 undergoing IVF

Exclusion Criteria:

- women > 45,

- women with one ovary,

- donor egg,

- surrogacy,

- FET cycles,

- uterine problems,

- large fibroids
We found this trial at
1
site
Virginia Center for Reproductive Medicine
Reston, Virginia 20190
?
mi
from
Reston, VA
Click here to add this to my saved trials